CHINA-BRITAIN-CORRUPTION-PHARMACEUTICAL-GSK : News Photo

CHINA-BRITAIN-CORRUPTION-PHARMACEUTICAL-GSK

The China headquarters of British company AstraZenica is seen in the Zhangjiang district of Shanghai on July 24, 2013. Beijing's targeting of British pharmaceutical giant GlaxoSmithKline (GSK) in a high-profile bribery probe is a reminder of the risks foreign companies face when seeking the huge rewards of China's market, analysts say. Police say GSK staff offered government officials and doctors bribes, and took kick-backs from travel agencies to organise conferences, some of which were fake. Chinese authorities have also questioned three Shanghai-based employees of Britain's AstraZeneca, detaining two, and have visited the offices of Belgium's UCB, according to the companies, although they did not specify what was being investigated. CHINA OUT AFP PHOTO (Photo credit should read STR/AFP/Getty Images)
Caption:
The China headquarters of British company AstraZenica is seen in the Zhangjiang district of Shanghai on July 24, 2013. Beijing's targeting of British pharmaceutical giant GlaxoSmithKline (GSK) in a high-profile bribery probe is a reminder of the risks foreign companies face when seeking the huge rewards of China's market, analysts say. Police say GSK staff offered government officials and doctors bribes, and took kick-backs from travel agencies to organise conferences, some of which were fake. Chinese authorities have also questioned three Shanghai-based employees of Britain's AstraZeneca, detaining two, and have visited the offices of Belgium's UCB, according to the companies, although they did not specify what was being investigated. CHINA OUT AFP PHOTO (Photo credit should read STR/AFP/Getty Images)
Calculate priceView cart
Date created:
July 24, 2013
Editorial #:
174324041
Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.CHINA OUT
License type:
Rights-managedRights-managed products are licensed with restrictions on usage, such as limitations on size, placement, duration of use and geographic distribution. You will be asked to submit information concerning your intended use of the product, which will determine the scope of usage rights granted.
Photographer:
STR / Stringer
Collection:
AFP
Credit:
AFP/Getty Images
Max file size:
3,552 x 2,368 px (49.33 x 32.89 in) - 72 dpi - 2.01 MB
Release info:
Not released.More information
Source:
AFP
Barcode:
AFP
Object name:
Hkg8819236

Keywords

This image is subject to copyright. Getty Images reserves the right to pursue unauthorized users of this image or clip, and to seek damages for copyright violations. To learn more about copyright and Getty Images’ enforcement program, click here. Availability for this image cannot be guaranteed until time of purchase.
The China headquarters of British company AstraZenica is seen in the... News Photo 174324041Asia,British Culture,Business,District,Finance,Headquarters,Horizontal,Illustration,Logo,Outdoors,Pharmacy,Research,Shanghai,SymbolPhotographer Collection: AFP 2013 AFPThe China headquarters of British company AstraZenica is seen in the Zhangjiang district of Shanghai on July 24, 2013. Beijing's targeting of British pharmaceutical giant GlaxoSmithKline (GSK) in a high-profile bribery probe is a reminder of the risks foreign companies face when seeking the huge rewards of China's market, analysts say. Police say GSK staff offered government officials and doctors bribes, and took kick-backs from travel agencies to organise conferences, some of which were fake. Chinese authorities have also questioned three Shanghai-based employees of Britain's AstraZeneca, detaining two, and have visited the offices of Belgium's UCB, according to the companies, although they did not specify what was being investigated. CHINA OUT AFP PHOTO (Photo credit should read STR/AFP/Getty Images)